Immunologic profiles in patients with chronic limb-threatening ischemia undergoing endovascular revascularization.
Jun LiShilpkumar AroraHeather WheatSiddhartha DashStephen KimuraJustin SmithYulanka Castro-DominguezClint OommenTarek A HammadMehdi H ShishehborSadeer Al-KindiDavid A ZidarPublished in: Vascular medicine (London, England) (2023)
The utilization of a periprocedural WBC subset differential can be a useful adjunct to risk-stratify patients with CLTI undergoing endovascular revascularization. Further studies are needed to understand potential ways to modulate immune dysregulation so as to improve mortality outcomes.
Keyphrases
- percutaneous coronary intervention
- coronary artery bypass grafting
- coronary artery disease
- acute coronary syndrome
- cardiovascular events
- aortic dissection
- risk factors
- cardiovascular disease
- type diabetes
- direct oral anticoagulants
- case control
- atrial fibrillation
- human health
- adipose tissue
- skeletal muscle
- insulin resistance